BP on Friday agreed to sell all its interests in purified
terephthalic acid (PTA) production in Malaysia to Indias Reliance Industries,
including its 610,000 tpy plant in Kuantan on the east coast of
Reliance has agreed to purchase BPs interest in the
plant for $230 million in cash. Both parties anticipate
completing the transaction in 2012.
This is an efficient plant with a good market position
in the region, said James Yim, head of BP's aromatics
business in Asia.
RECRON Malaysia, part of the Reliance Group, is
already our largest customer in Malaysia and Reliance
Industries is a significant feedstock supplier at Kuantan, so
Reliance is a natural owner of this plant.
Nick Elmslie, CEO of BP Petrochemicals, said: BP has a
major, global PTA business, with around one fifth of global PTA
production capacity and a track record of leading technology.
We will continue to concentrate our PTA strategy on
deploying new technologies into high growth markets like China
where we are in the middle of a considerable expansion program, and in OECD
markets where our technology gives us an advantage and
high utilization rates, he added.
We are also building new revenue streams by licensing
our PTA and paraxylene technologies.
All current plant staff members are expected to transfer to
the new owners under equivalent terms and conditions, according
to officials involved with the sale.
BPs acetic acid manufacturing and marketing business
in Malaysia is unaffected by this sale.